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Objectives The aim of this study was to explore post–myocardial infarction (MI) myocardial inflammation.
Background Innate immune cells are centrally involved in infarct healing and are emerging therapeutic targets in cardiovas-
cular disease; however, clinical tools to assess their presence in tissue are scarce. Furthermore, it is currently
not known if the nonischemic remote zone recruits monocytes.
Methods Acute inflammation was followed in mice with coronary ligation by 18-fluorodeoxyglucose (18FDG) positron emis-
sion tomography/magnetic resonance imaging, fluorescence-activated cell sorting, polymerase chain reaction,
and histology.
Results Gd-DTPA–enhanced infarcts showed high 18FDG uptake on day 5 after MI. Cell depletion and isolation data
confirmed that this largely reflected inflammation; CD11b cells had 4-fold higher 18FDG uptake than the
infarct tissue from which they were isolated (p  0.01). Surprisingly, there was considerable monocyte re-
cruitment in the remote myocardium (approximately 104/mg of myocardium, 5.6-fold increase; p  0.01),
a finding mirrored by macrophage infiltration in the remote myocardium of patients with acute MI. Tempo-
ral kinetics of cell recruitment were slower than in the infarct, with peak numbers on day 10 after isch-
emia. Quantitative polymerase chain reaction showed a robust increase of recruiting adhesion molecules
and chemokines in the remote myocardium (e.g., 12-fold increase of monocyte chemoattractant protein-1),
although levels were always lower than in the infarct. Finally, matrix metalloproteinase activity was signifi-
cantly increased in noninfarcted myocardium, suggesting that monocyte recruitment to the remote zone
may contribute to post-MI dilation.
Conclusions This study shed light on the innate inflammatory response in remote myocardium after MI. (J Am Coll Cardiol
2012;59:153–63) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.08.066Myocardial infarction (MI) triggers a robust local inflamma-
tory response (1,2). On the cellular level, the innate immune
system reacts to ischemic injury with mobilization of neutro-
phils and monocytes during the first weeks after ischemia. The
amplitude and duration of inflammation and its timely reso-
lution influence post-MI remodeling and the evolution of
heart failure; hence, these cells and their recruiting mechanisms
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PET/MRI in Acute MI January 10, 2012:153–63myocyte hypertrophy, myocyte ap-
optosis, and remodeling of the col-
lagen matrix occur here and sub-
stantially contribute to the dilation
of the heart after MI (3–6), the
nonischemic myocardium deserves
closer scrutiny. One reason for the
limited insight into inflammatory
processes after MI, at least in pa-
tients, is the paucity of imaging
tools to study tissue levels of in-
flammatory cells (7).
Emerging hybrid positron
emission tomography (PET)/
magnetic resonance imaging (MRI) has considerable
potential for cardiovascular imaging because it combines
PET, a highly sensitive and quantitative modality that
Figure 1 Experimental Set-Up
(A and B) Fiducial vest. (C) Multimodality imaging bed connects to gurneys on po
nance imaging (MRI) (E) to allow for a no-touch transfer of the mouse between mo
Three-dimensional CT data show the skeleton and a part of the fiducial marker in
acquisition are applied. (J) Fiducials visible on CT and MRI are aligned. (K) Three-
(M and N) Double-angulated diastolic and systolic PET/MRI short-axis views.
Abbreviations
and Acronyms
18FDG 
18-fluorodeoxyglucose
CT  computed
tomography
FDG  fluorodeoxyglucose
MI  myocardial infarction
MRI  magnetic resonance
imaging
PET  positron emission
tomographycan follow rare molecular events (8,9), with MRI, which
noninvasively assesses cardiovascular anatomy and func-
tion, infarct size, perfusion, myocardial strain, and me-
tabolism with excellent spatial and temporal resolution
(10 –14). Combining both modalities could enhance pre-
clinical research by providing multidimensional “systems”
data and is also likely to directly impact clinical imaging
(15–17). Here we devised a fusion method that relies on
a fiducial vest developed for cardiovascular imaging in
mice with separate scanners. We hypothesized that when
glucose usage is suppressed in myocytes, the temporal and
spatial 18-fluorodeoxyglucose (18FDG) signal pattern
ay reflect inflammatory cell activity in the heart. We
hen explored the recruitment of monocytes to nonisch-
mic remote myocardium after coronary ligation in mice,
sing imaging in conjunction with flow cytometric cell
uantitation.
emission tomography/computed tomography (PET/CT) (D) and magnetic reso-
s (F and G), ensuring that no major position changes hamper data fusion. (H)
I) CT and MRI matrices are matched, and the angles used during cardiac MRI
sional data from PET/CT/MRI. (L) CT information is phased out to yield PET/MRI.sitron
dalitie
blue. (
dimen
P
c
0
m
(
F
f
s
D
M
e
w
m
F
e
t c
fi
e
a
155JACC Vol. 59, No. 2, 2012 Lee et al.
January 10, 2012:153–63 PET/MRI in Acute MIMethods
Please see the Online Appendix for additional information.
PET/computed tomography. Mice were imaged by
microPET/computed tomography (CT) using an Inveon
(Siemens Medical Solutions, Inc., Malvern, Pennsylvania)
small-animal scanner 1 h after intravenous (IV) injection of
20.7 0.9 MBq 18FDG through the tail vein. CT preceded
PET, acquiring 360 cone beam projections with a source
power and current of 80 keV and 500 A, respectively.
rojections were reconstructed into 3-dimensional volumes
ontaining 512  512  768 voxels with the dimension of
.11  0.11  0.11 mm. Gated PET was acquired for 30
in using electrocardiogram leads and a respiratory pillow
m2m Imaging Corp., Cleveland, Ohio). A high-resolution
ourier rebinning algorithm was used to rebin sinograms,
ollowed by a filtered back-projection algorithm for recon-
truction. Image voxel size was 0.797 0.861 0.861 mm.
ata were calculated as mean standardized uptake values.
agnetic resonance imaging. We obtained delayed-
nhancement cine images on a 7-T Bruker Pharmascan
ith electrocardiogram and respiratory gating (SA Instru-
ents, Inc., Stony Brook, New York), a gradient echo
LASH sequence with the following imaging parameters:
cho time 2.7 ms; 16 frames per R-R interval (repetition
ime 7.0 to 15 ms); resolution 200 m  200 m  1 mm;
number of excitations 4; flip angle 60°. Imaging was done 10
to 20 min after IV injection of 0.3 mmol/kg gadolinium–
diethylene triamine pentaacetic acid (Gd-DTPA) (19,20).
Figure 2 Colocalization
A 3-modality phantom was used to assess the developed work flow. Fiducials line
chamber contains water only, and the inside contains 18F. The mesh diagram disp
Pearson correlation coefficient (PC) of 0.91  0.02. When PET and MRI are transl
ers. Other abbreviations as in Figure 1.Registration/fusion. PET/MRI fusion was facilitated by a
custom-designed mouse bed and a PET/CT gantry adapter.
These hardware components facilitated intermodal transfer,
minimized animal motion, and allowed us to center the mouse
at nearly identical coordinates in MRI and PET/CT scanners.
A “framed fusion” approach was then implemented (21) using
external fiducial landmarks. The fiducials were provided by a
custom-built “vest” (Fig. 1) made of several loops of PE50
tubing. The vest tightly surrounded the mouse’s chest, provid-
ing a rigid frame that followed movements of the animal
during transfer. The tubes were filled with 15% iodine in water,
rendering them visible in both CT and MRI. The tubes’
orientation was optimized to provide unique landmarks for
MRI and CT data registration (outlined in Fig. 1). PET data
were fused to CT as part of a standard PET/CT workflow.
Registration of MRI and CT data sets was obtained by
computing the rigid transformation necessary to superim-
pose the fiducials via a 2-step process. The first step
accomplished rough alignment of data sets based on the
holder position within each modality, followed by transla-
tional and rotational alignment via a cross-correlation algo-
rithm. Fused data sets were used to place volumes of interest
for quantitation of PET signal. Colocalization achieved by
this procedure was tested with an 18F phantom using the
ross-correlation function (22). The peak correlation coef-
cient of 5 MRI and PET slices was 0.91  0.02, implying
xcellent coregistration of signal distribution between PET
nd MRI (Fig. 2).
terior of the phantom, which is composed of 2 concentric chambers. The outer
e correlation of PET and MR signal after fusion. The data sets correlate with a
long the y- or x-axis, the correlation drops rapidly. Arrows point at fiducial mark-the ex
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PET/MRI in Acute MI January 10, 2012:153–63Clinical PET/CT. Clinical PET/CT was obtained on day
5 after MI after obtaining informed consent and approval of
the institutional committee. To limit myocyte uptake of
18FDG, patients received a high-fat, low-carbohydrate diet
the evening before imaging, fasted for 12 h before imaging,
and were given beta-blockers IV and a lipid-rich drink (very
low carbohydrate Atkins shake) 90 min before 18FDG
njection (23).
low cytometry. Flow cytometry was performed on days 1
o 14 post-MI (n  3 to 4 per group) (24). Hearts were
ivided into MI and remote myocardium, digested in
nzyme mixture, and passed through a cell strainer. Single-
ell suspensions were stained with the following antibodies:
D11b-APC-Cy7, B220-PE, CD49b-PE, NK1.1-PE,
D90-PE, Ly-6G-PE, Ter119-PE, F4/80-PE-Cy7, and Ly-
C-FITC (BD Biosciences, San Jose, California). Monocytes/
acrophages were defined as CD11bhigh (B220/CD49b/
K1.1/CD90/Ly-6G/Ter119)low. Monocyte subsets were
Figure 3 18FDG PET/Gd-DTPA MRI
(A to D) 18-fluorodeoxyglucose (18FDG) PET/MRI long- and short-axis views acquir
show PET signal. MRI used delayed-enhancement cine gradient echo. Autoradiogra
Insets depict the infarct as unstained pale tissue on triphenyltetrazolium chloride.
respective anesthesia (mean  SEM; *p  0.01). (H and I) 18FDG PET/CT in a p
injured inferior left ventricular wall. Abbreviations as in Figure 1.identified as CD11bhigh (B220/CD49b/NK1.1/CD90/Ly-
G/Ter119)lowF4/80low Ly-6Chigh or Ly-6Clow. Flow cytom-
try was performed using a multicolor flow cytometer (LSR II,
D Biosciences).
easurement of activity in monocytes/macrophages isolated
rom infarcts. 18FDG was injected IV (n  6). Three hours
ater hearts were removed, and activity in infarcts was measured
y gamma counting. Afterward, tissue was treated as described
reviously to produce cell suspensions. Cells were stained with
D11b-PE, followed by incubation with anti-PE magnetic
eads (Miltenyi Biotec Inc., Auburn, California) and separated
ith MACS columns. Activity of magnetically retrieved cells
as measured by gamma counting.
Cx3cr1gfp/ mice (n  3) were used to measure the
diameter of splenic monocytes (25) to calculate monocyte
weight. This was necessary to compare cell and tissue
activity, both normalized to weight. In mice anesthetized
with isoflurane, the spleen was imaged with intravital
ice on day 5 after myocardial infarction (MI) using different anesthesias. Insets
short-axis rings in mice with isoflurane (Iso) (E) vs. ketamine/xylazine (K/X) (F).
farct to remote myocardium standardized uptake value ratio in 18FDG scans with
5 days after right coronary artery occlusion showed increased PET signal in theed in m
phy of
(G) In
atient
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January 10, 2012:153–63 PET/MRI in Acute MIFigure 4 18FDG Uptake is Linked to Presence of CD11b Monocytes/Macrophages
(A) Experimental set-up. Mice were injected, and activity in infarct was assessed by scintillation counting. Thereafter, CD11b monocytes/macrophages (M) were iso-
lated from the same infarct tissue by positive selection with antibodies coupled to magnetic beads. (B) To express gamma counts normalized to cellular weight, mean
cell diameter was measured by intravital microscopy (IVM). The mean monocytic diameter was then used to calculate cell volume and weight. Scale bar  15 m. (C)
Activity of monocytes/macrophages and the tissue from which they were isolated. (D) Counts per min (CPM) for cell types isolated from infarct tissue. (E) PET/MRI on
day 5 after MI, followed by ex vivo counting. (F) Fluorescence-activated cell sorting enumeration (upper panels) and immunohistochemical (IHC) staining (lower panels)
of monocytes/macrophages in infarcts (mean  SEM; *p  0.05). Scale bar  30 m. EC  endothelial cells; GFP  green fluorescent protein; %IDGT  percent
injected dose/gram of tissue; M depl  monocyte/macrophage depletion with clodronate liposomes; SUV  standardized uptake value; other abbreviations as in
Figures 1 and 3.Figure 5 18FDG PET/MRI at Different Time Points After MI
Arrows in insets point at infarct in delayed-enhancement MRI. Numbers in PET/MR images show the SUV of presented cases (mean  SEM; *p  0.05, **p  0.01).
Con  noninfarcted control group; %IDGT  % injected dose/gram tissue; RM  remote myocardium; other abbreviations as in Figures 1, 3, and 4.
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PET/MRI in Acute MI January 10, 2012:153–63microscopy as previously described (26,27) using an intrav-
ital laser scanning microscope (IV100, Olympus).
Immunohistochemistry on human myocardial tissue.
Myocardial tissue was collected from 11 patients with an
infarct age of 5 to 14 days who were referred to the department
of pathology, VU University Medical Center, Amsterdam, the
Netherlands (mean age 62  16 years, 45% male). Tissue was
obtained from the infarct zone (left ventricle) and the remote
myocardium (right ventricle). Of note, we cannot exclude that
coronary arteries supplying the remote myocardium were
completely free of disease in these patients. Control tissue was
Figure 6 M Accumulation in Infarct and Remote Myocardium
(A) Fluorescence-activated cell sorting analysis of CD11b cells (gate in dot plots
cence microscopy of GFP monocytes. Scale bar  25 m. Bar graphs show GFP
are accentuated in the border zone, where we frequently observed high PET signal
delayed-enhancement MRI (inset) and PET/MRI long-axis view on day 5 with typica
polymerase chain reaction analysis in MI and nonischemic remote myocardium on
DAPI  4’,6-diamidino-2-phenylindole; MCP  monocyte chemoattractant protein; VCobtained from 8 patients who died from a cause not related
to MI (4 men, mean age 61  16 years, 50% male). None
of the patients in this study received reperfusion therapy.
The study was conducted in accordance with the Declara-
tion of Helsinki, and the study protocol was approved by the
institutional medical ethics committee. Tissue was fixed in
formalin, embedded in paraffin, cut in 4-m–thick sections,
and stained with an antibody for human CD68 (Dako,
Glostrup, Denmark). Quantification of macrophages was
performed by counting the number of extravascular CD68
macrophages.
ferent time points in the infarct and remote myocardium. (B) Immunofluores-
counted per high power field (HPF) at 200 magnification. (C) CD11b cells
le bar  0.1 mm in upper panel and 30 m in lower panel. On the right,
er zone (arrows) configuration of signal. (D) Quantitative reverse transcriptase
after MI (mean  SEM; *p  0.05). CCR2  chemokine (C-C motif) receptor 2;
vascular cellular adhesion molecule; other abbreviations as in Figures 1, 3, 4, and 5.) at dif
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January 10, 2012:153–63 PET/MRI in Acute MIResults
Myocardial 18FDG signal. PET/MR images (18FDG PET
ombined with delayed-enhancement MRI after injection
f Gd-DTPA) and ex vivo autoradiography in conjunction
ith triphenyltetrazolium chloride staining showed that
etamine/xylazine anesthesia suppressed uptake in the re-
ote myocardium and unmasked the increased PET signal
n infarcts on day 5 after MI (Fig. 3). Specifically, the infarct
o remote myocardium signal ratio changed from 0.33 0.1
ith isoflurane to 1.56  0.1 using ketamine/xylazine (p 
.05) (Fig. 3G). To explore whether 18FDG could be used
o follow infarct inflammation in humans, we imaged a
atient 5 days after inferior MI. In this patient, occlusive
hrombosis of the right coronary artery was verified by x-ray
oronary angiography and treated by placement of a stent.
ET images showed increased 18FDG signal within the
inferior left ventricular wall (Figs. 3H and 3I).
18FDG uptake in monocytes/macrophages. We per-
formed several experiments to determine if monocytes/
macrophages in the infarct contained 18FDG after IV
njection of the PET agent. First we isolated monocytes/
acrophages from infarcts and measured activity in these
urified cell populations as outlined in Figure 4A. Tradi-
ionally, reported tissue activity is normalized to weight. To
alculate monocyte weight using the radius, volume, and
ensity, we measured the diameter of monocytes by intra-
ital microscopy (13.2  1.0 m) (Fig. 4B). The calculated
average cellular weight was 1.3 ng. This number was then
used to normalize 18FDG activity to weight by multiplica-
ion with the cell number in the sample. The activity of cells
solated from infarcts was significantly higher than the
Figure 7 MCP-1 and VCAM-1 Expression in Remote Myocardiu
On day 5 after MI, immunohistochemical and immunofluorescence staining showed expre
Scale bar  20 m on IHC and 10 m on immunofluorescence images. Abbreviatctivity of the infarct tissue from which they were retrieved
Fig. 4C). We also isolated monocyte/macrophages, endo-
helial cells, and fibroblasts from infarcts after IV 18FDG
njection. Scintillation counting revealed that the cellular
ctivity was highest in monocytes/macrophages (Fig. 4D).
Next we depleted monocytes/macrophages with clodro-
ate liposomes and imaged these mice on day 5 after MI.
epletion reduced the in vivo infarct activity by 34% (Fig. 4E).
cintillation counting of infarct tissue showed a 37% decrease
f activity (Fig. 4E). Immunohistochemistry and flow cyto-
etric enumeration confirmed a reduction of monocyte/
acrophage numbers by 35%, comparable to the decrease in
18FDG signal (Fig. 4F). On day 10 after MI, depletion
reduced the infarct signal by 31% (n 6 per group; p 0.05).
Time course of 18FDG PET signal. There was signifi-
antly increased uptake in the infarct of mice on day 5 after
oronary ligation (standardized uptake value 2.7  0.1)
Fig. 5) when compared with myocardium in control mice
1.3  0.2; p  0.01). On day 14, the 18FDG signal
approached control values (MI 1.6  0.1; remote 1.4 
0.1). Scintillation counting corroborated the imaging results
(Fig. 5). Interestingly, we found differences between the
activity in noninfarcted remote myocardium on day 5
after MI and control hearts (percent injected dose/gram
of tissue, remote 8.9  0.5; control 5.1  1.0; p  0.05).
The MRI component of hybrid datasets enabled the
precise definition of the infarct area and analysis of
anatomic and functional parameters. The infarct size was
30%  2% in the studied cohorts. Wall thickening was
reduced in the infarcted area (remote 45%  5%; infarct
10%  5%; p  0.01).
f the chemokine and adhesion molecule, which colocalized with endothelial cells.
s in Figures 3, 4, 5, and 6.m
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PET/MRI in Acute MI January 10, 2012:153–63Monocyte/macrophage recruitment. Surprisingly, we
found monocyte/macrophage recruitment in the nonin-
farcted remote myocardium (Fig. 6A). The number of
CD11b cells counted by fluorescence-activated cell sorting
was lower than in the infarct and reached a later peak
around day 10. Immunofluorescent cell quantitation by
histology corroborated these findings (Fig. 6B). In some
cases, monocyte/macrophages were most numerous in the
border zone of the infarct (Fig. 6C), which may explain why
we observed the peak PET signal at the edge of large
infarcts (Fig. 6C).
Finding monocytes/macrophages in the nonischemic re-
mote zone motivated us to study chemokine and adhesion
molecule expression typically involved in cell recruitment
(1). mRNA of chemokine (C-C motif) receptor 2 (CCR2),
which is highly expressed by monocytes, was increased
66-fold in the infarct and 9-fold in the remote zone on day
5 after MI (Fig. 6D). P-Selectin, E-selectin and vascular cell
Figure 8 Monocyte Subsets in Remote Myocardium
(A) Fluorescence-activated cell sorting dot plots gated on CD11b lineage cells sho
(B) Bar graphs of absolute number of monocyte subsets in MI and remote myoadhesion molecule 1 (VCAM-1) expression were mildly
increased (Fig. 6D). Monocyte chemoattractant protein 1
(MCP-1), MCP-3, MCP-5, and fractalkine were also
upregulated in the remote zone when compared with
control myocardium from noninfarcted hearts (12-fold,
18-fold, 9-fold, and 3-fold, respectively; p  0.05) (Fig.
6D). Immunohistochemical and immunofluorescence
studies showed expression of MCP-1 and VCAM-1 in
the remote zone, which colocalized with endothelial cells
(Fig. 7). Profiling for monocyte subsets in the remote
myocardium revealed that Ly-6Chigh monocytes were
ecruited early and were followed by Ly-6Clow mono-
cytes, which peaked at day 10 after MI, approximately 5
days later when compared with cell dynamics in the
infarct (Fig. 8). Analysis of clinical specimens obtained
from autopsy cases after acute MI revealed robust recruit-
ment of CD68 macrophages to the noninfarcted myo-
cardium in patients (Fig. 9).
rial change of M in MI and remote myocardium. Control  noninfarcted mouse.
m (mean  SEM; *p  0.05). Abbreviations as in Figures 3, 4, and 5.wed se
cardiu
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January 10, 2012:153–63 PET/MRI in Acute MIProtease activity. Finally, we assessed the activity of
matrix metalloproteinase (MMP)-2 and MMP-9 using
an activatable fluorescence reporter. Although fluores-
cence intensity was highest in the infarct, we found
significant activation of the probe in the remote zone and
septum (Fig. 10).
Discussion
The data presented here reflected the spatial and tempo-
ral kinetics of innate immune cells after MI and explored
the use of 18FDG PET for following infarct inflamma-
tion. Early after ischemia, monocytes and macrophages
infiltrated injured tissue in large numbers. These innate
immune cells are emerging as key regulators of infarct
healing (1,2). Previous studies have shown that mono-
cytes/macrophages are present in the ischemic myocar-
dium during the first 2 weeks after ischemic injury and
Figure 9 CD68 Cells in Heart Tissue of Patients
Histology images of immunoreactive CD68 staining (top row) and hematoxylin and eo
graph displays quantification of CD68 cells in respective cardiac tissue samples from
Figure 10 Matrix Metalloproteinase Activity in Remote Myocar
(A) Target to background ratio (TBR) after injection of protease sensor (mean  S
shows protease sensor activation in the remote myocardium (inset, right panel) (orchestrate tissue repair (18,24). They remove debris,
enhance neoangiogenesis, release a myriad of inflamma-
tory cytokines, and are a major source of proteases that
regulate the turnover of extracellular matrix. Preclinical
studies have revealed that proper infarct healing calls for
a delicate balance of monocyte activity (2). Excessive as
well as insufficient monocyte/macrophage numbers in the
infarct compromise cardiac repair and lead to infarct
expansion, aggressive left ventricular dilation, and ulti-
mately, heart failure. Studies correlating the number of
circulating blood pool monocytes at the time of infarction
with clinical outcome have suggested that the preceding
preclinical data reflect infarct healing in patients (28 –30).
Although the presence, time course, and function of
innate immune cells in the infarct have been well described,
our finding of inflammation in the remote zone is new and
somewhat surprising. The number of monocytes/
E) staining (bottom row) at 200 magnification (mean  SEM; *p  0.05). The
nts with MI. Abbreviation as in Figure 3.
p  0.05). (B) Fluorescence reflectance image of short-axis ring 6 days after MI
 SEM; *p  0.05). *MI. Abbreviations as in Figures 3 and 5.sin (H&
patiedium
EM; *
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PET/MRI in Acute MI January 10, 2012:153–63macrophages in the noninfarcted myocardium was lower
than in the ischemic tissue; however, their numbers detected
by flow cytometry were substantial (approximately 104 per mg
of tissue, 5.6-fold higher than in control mice). The time
course was in accordance with the 2 monocytic phases
described in the infarct (24), but the kinetics were slower.
Peak cell numbers were reached on day 10 after MI, 5 days
later than in the ischemic zone. Exploring the mechanism of
recruitment, we also found increased expression of adhesion
molecules and the chemokines known to recruit monocytes
into the infarct (1,2). Tissue obtained from clinical autopsies
showed a robust increase of macrophages in the remote
myocardium of patients that died on day 5 to 14 after the
ischemic event. The finding of higher MMP activity in the
remote zone of mice indicated that these inflammatory
processes are involved in remodeling of the left ventricle
after ischemic injury, although the precise cellular contribu-
tion of MMP activity is unclear at this point. Future studies
are required to dissect the molecular mechanism of how
inflammation in the nonischemic myocardium is triggered.
The expression of recruiting molecules such as VCAM-1
and MCP-1 argues against a mere “spill over” effect from
the infarct. One could speculate that apoptosis of remote
myocytes may trigger cell recruitment or that systemically
increased angiotensin 2 activates endothelium in the remote
zone.
We presented data showing that within subacutely
infarcted myocardium, 18FDG accumulated relative to
the tissue’s monocyte/macrophage content. PET signal
changed synchronously with the number of innate im-
mune cells, mirrored their typical spatial distribution
after MI, and decreased in scale to cell numbers in a
monocyte/macrophage depletion experiment. Further-
more, monocytes/macrophages isolated from infarcts
showed high 18FDG uptake. This evidence suggested
that the infarct signal on day 5 after ischemia reflects—at
least in part—inflammatory activity. Because 18F decays
with a half-life of 110 min, serial noninvasive spatiotem-
poral imaging of inflammation appears feasible.
The use of 18FDG to image inflammation in myocar-
ium has limitations. Myocytes can metabolize glucose
nd therefore show high 18FDG uptake. Residual viable
yocytes in the infarct may contribute to signal. Accord-
ngly, suppression of this uptake is a prerequisite for
maging of inflammatory cells. Clinically, methods sup-
ressing myocardial uptake have been developed to image
nflammation in coronary arteries (23,31), and the clinical
ET/CT case discussed in Figure 3 suggests that these
trategies may also prove useful for imaging inflammation
n the myocardium. Acutely ischemic and hibernating
yocardium shifts its metabolic use of fatty acids toward
lucose (32), which results in increased 18FDG uptake
and may change the observed relationship between
18FDG uptake and monocyte/macrophage activity. Novel
PET tracers that specifically target monocytes/macrophagescould overcome these limitations (33,34); however, 18FDG
s clinically approved and could be explored now.
onclusions
he obtained data showcased the synergy created by fusing
igh-resolution cardiac PET with MRI. Using separate
ystems and offline fusion circumvents engineering chal-
enges faced in hybrid scanners, in which deploying PET in
magnetic field currently compromises sensitivity. Com-
ining leading modalities for molecular and anatomic car-
iovascular imaging holds promise for a number of inter-
sting future applications. Data on cardiac metabolism,
olecular pathways, cell populations, or drug targets could
e integrated with parameters such as myocardial motion,
train, torsion, or perfusion. Such integration could foster
odeling and systems biology approaches to provide novel
nsight into better treating heart failure.
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